{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T21:21:42Z","timestamp":1787952102965,"version":"build-2784847793"},"reference-count":109,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.blre.2026.101418","type":"journal-article","created":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T06:49:28Z","timestamp":1783406968000},"page":"101418","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Biomarkers of joint and bone diseases, and their associations to haemophilic arthropathy in people with haemophilia: A first systematic review"],"prefix":"10.1016","volume":"77","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-4507-0524","authenticated-orcid":false,"given":"M.","family":"Piccand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5577-7306","authenticated-orcid":false,"given":"A.","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4117-9257","authenticated-orcid":false,"given":"H.","family":"Stephan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1559-1731","authenticated-orcid":false,"given":"U.F.","family":"Wehmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1738-4891","authenticated-orcid":false,"given":"F.","family":"Tomschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0935-2526","authenticated-orcid":false,"given":"T.","family":"Hilberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.blre.2026.101418_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2020.100781","article-title":"Biochemical marker research in hemophilic arthropathy: a systematic review","volume":"47","author":"Van Bergen","year":"2021","journal-title":"Blood Rev"},{"issue":"2","key":"10.1016\/j.blre.2026.101418_bb0010","doi-asserted-by":"crossref","DOI":"10.1111\/1756-185X.15061","article-title":"Stromal cell-derived factor 1 alpha (SDF -1alfa) and cartilage oligomeric matrix protein (COMP): two potential signature biomarkers of radiological detectable hemophilic arthropathy","volume":"27","author":"Leuci","year":"2024","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.blre.2026.101418_bb0015","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.phrs.2016.11.032","article-title":"Pathophysiology of hemophilic arthropathy and potential targets for therapy","volume":"115","author":"Pulles","year":"2017","journal-title":"Pharmacol Res"},{"issue":"4","key":"10.1016\/j.blre.2026.101418_bb0020","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/hae.12375","article-title":"The burden of bleeding in haemophilia: is one bleed too many?","volume":"20","author":"Gringeri","year":"2014","journal-title":"Haemophilia"},{"issue":"2","key":"10.1016\/j.blre.2026.101418_bb0025","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1111\/hae.14734","article-title":"Synovitis and joint health in patients with haemophilia: Statements from a European e-Delphi consensus study","volume":"29","author":"Mancuso","year":"2023","journal-title":"Haemophilia"},{"issue":"3","key":"10.1016\/j.blre.2026.101418_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2023.102308","article-title":"The evolution of hemophilia therapeutics: an illustrated review","volume":"8","author":"Espa\u00f1ol","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.blre.2026.101418_bb0035","series-title":"FDA Approves Drug to Prevent or Reduce the Frequency of Bleeding Episodes for Patients With Hemophilia A With Inhibitors or Hemophilia B With Inhibitors","author":"Research C for DE","year":"2024"},{"key":"10.1016\/j.blre.2026.101418_bb0040","unstructured":"Alhemo | European Medicines Agency (EMA) [Internet]. 2025 [cit\u00e9 28 avr 2025]. Disponible sur: https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/alhemo."},{"key":"10.1016\/j.blre.2026.101418_bb0045","series-title":"FDA Approves New Treatment for Hemophilia A or B","author":"Commissioner O of the. FDA [Internet]","year":"2024"},{"key":"10.1016\/j.blre.2026.101418_bb0050","author":"Hympavzi | European Medicines Agency (EMA) [Internet]"},{"key":"10.1016\/j.blre.2026.101418_bb0055","author":"Commissioner O of the. FDA [Internet]. FDA"},{"key":"10.1016\/j.blre.2026.101418_bb0060","author":"Research C for BE and. ALTUVIIIO. FDA [Internet]"},{"key":"10.1016\/j.blre.2026.101418_bb0065","author":"Altuvoct | European Medicines Agency (EMA) [Internet]"},{"key":"10.1016\/j.blre.2026.101418_bb0070","author":"Research C for BE and ROCTAVIAN. FDA [Internet]"},{"key":"10.1016\/j.blre.2026.101418_bb0075","author":"Roctavian | European Medicines Agency (EMA) [Internet]"},{"issue":"1","key":"10.1016\/j.blre.2026.101418_bb0080","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-052358","article-title":"Twelve-month prevalence of haemarthrosis and joint disease using the Haemophilia Joint Health score: evaluation of the UK National Haemophilia Database and Haemtrack patient reported data: an observational study","volume":"12","author":"Wilkins","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/j.blre.2026.101418_bb0085","doi-asserted-by":"crossref","DOI":"10.1177\/20406207231218624","article-title":"The effectiveness and safety of octocog alfa in patients with hemophilia A: up to 7-year follow-up of the real-world AHEAD international study","volume":"15","author":"Ozelo","year":"2024","journal-title":"Ther Adv Hematol"},{"issue":"1","key":"10.1016\/j.blre.2026.101418_bb0090","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/hae.13361","article-title":"Pattern of bleeding in a large prospective cohort of haemophilia A patients: A three-year follow-up of the AHEAD (Advate in HaEmophilia A outcome Database) study","volume":"24","author":"Khair","year":"2018","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2026.101418_bb0095","doi-asserted-by":"crossref","DOI":"10.1177\/20406207241295653","article-title":"Efficacy of emicizumab in patients with severe haemophilia A without factor VIII inhibitors in Germany: evaluation of real-life data documented by the smart medication eDiary","volume":"15","author":"Escuriola Ettingshausen","year":"2024","journal-title":"Ther Adv Hematol"},{"issue":"11","key":"10.1016\/j.blre.2026.101418_bb0100","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1182\/bloodadvances.2023012285","article-title":"Predictive parameters for spontaneous joint bleeding during emicizumab prophylaxis","volume":"8","author":"Arcudi","year":"2024","journal-title":"Blood Adv"},{"issue":"1","key":"10.1016\/j.blre.2026.101418_bb0105","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/hae.13877","article-title":"Emicizumab prophylaxis in patients with haemophilia A with and without inhibitors","volume":"26","author":"Ebbert","year":"2020","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2026.101418_bb0110","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa067659","article-title":"Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia","author":"Manco-Johnson","year":"2007","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.blre.2026.101418_bb0115","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/hae.14441","article-title":"Clinical assessment and point of care ultrasonography: how to diagnose haemophilic synovitis","volume":"28","author":"De La Corte-Rodriguez","year":"2022","journal-title":"Haemophilia"},{"issue":"13","key":"10.1016\/j.blre.2026.101418_bb0120","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1182\/blood-2015-01-528414","article-title":"Optimal treatment strategies for hemophilia: achievements and limitations of current prophylactic regimens","volume":"125","author":"Oldenburg","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101418_bb0125","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2147\/JBM.S304597","article-title":"Asymptomatic joint bleeding and joint health in hemophilia: a review of variables, methods, and biomarkers","volume":"12","author":"Gooding","year":"2021","journal-title":"J Blood Med"},{"issue":"2","key":"10.1016\/j.blre.2026.101418_bb0130","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/hae.14934","article-title":"Expert United Kingdom consensus on the preservation of joint health in people with moderate and severe haemophilia A: a modified Delphi panel","volume":"30","author":"Laffan","year":"2024","journal-title":"Haemophilia"},{"key":"10.1016\/j.blre.2026.101418_bb0135","author":"086-005l_S2k_Synovitis-bei-Haemophilie_2023-02.pdf [Internet]"},{"issue":"4","key":"10.1016\/j.blre.2026.101418_bb0140","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1056\/NEJMoa2209226","article-title":"Efanesoctocog alfa prophylaxis for patients with severe hemophilia A","volume":"388","author":"Von Drygalski","year":"2023","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.blre.2026.101418_bb0145","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa2312611","article-title":"Efanesoctocog alfa prophylaxis for children with severe hemophilia A","volume":"391","author":"Malec","year":"2024","journal-title":"N Engl J Med"},{"issue":"19","key":"10.1016\/j.blre.2026.101418_bb0150","doi-asserted-by":"crossref","first-page":"7292","DOI":"10.3390\/ijms21197292","article-title":"The progression of hemophilic arthropathy: the role of biomarkers","volume":"21","author":"Pasta","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"2","key":"10.1016\/j.blre.2026.101418_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2023.101852","article-title":"Biomarkers for osteoarthritis: current status and future prospects","volume":"37","author":"Mobasheri","year":"2023","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.blre.2026.101418_bb0160","first-page":"295","article-title":"Clinical and omics biomarkers in osteoarthritis diagnosis and treatment","volume":"50","author":"Deng","year":"2025","journal-title":"J Orthop Transl"},{"issue":"4","key":"10.1016\/j.blre.2026.101418_bb0165","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1586\/17474086.2016.1141674","article-title":"Synovium and cartilage biomarkers in hemophilic arthropathy","volume":"9","author":"Rodriguez-Merchan","year":"2016","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.blre.2026.101418_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.100642","article-title":"Serological biomarkers in hemophilic arthropathy: can they be used to monitor bleeding and ongoing progression of blood-induced joint disease in patients with hemophilia?","volume":"41","author":"Rodriguez-Merchan","year":"2020","journal-title":"Blood Rev"},{"issue":"18","key":"10.1016\/j.blre.2026.101418_bb0175","doi-asserted-by":"crossref","first-page":"9897","DOI":"10.3390\/ijms25189897","article-title":"Biomarkers involved in the pathogenesis of hemophilic arthropathy","volume":"25","author":"Badulescu","year":"2024","journal-title":"Int J Mol Sci"},{"issue":"11","key":"10.1016\/j.blre.2026.101418_bb0180","doi-asserted-by":"crossref","DOI":"10.1002\/mgg3.979","article-title":"Genetic biomarkers related to hemarthrosis, inflammation, and cartilage structure in pediatric patients with hemophilic arthropathy","volume":"7","author":"L\u00f3pez-Jim\u00e9nez","year":"2019","journal-title":"Mol Genet Genomic Med"},{"issue":"3","key":"10.1016\/j.blre.2026.101418_bb0545","doi-asserted-by":"crossref","first-page":"401","DOI":"10.11124\/JBIES-24-00523","article-title":"The revised JBI critical appraisal tool for the assessment of risk of bias for analytical cross-sectional studies","volume":"24","author":"Barker","year":"2026","journal-title":"JBI Evid Synth. mars"},{"issue":"4","key":"10.1016\/j.blre.2026.101418_bb0185","doi-asserted-by":"crossref","DOI":"10.1111\/hae.13196","article-title":"Serological biomarkers detect active joint destruction and inflammation in patients with haemophilic arthropathy","volume":"23","author":"Hua","year":"2017","journal-title":"Haemophilia"},{"issue":"6","key":"10.1016\/j.blre.2026.101418_bb0190","doi-asserted-by":"crossref","DOI":"10.1111\/hae.14154","article-title":"3D gait analysis, haemophilia joint health score, leg muscle laterality and biomarkers of joint damage: a cross-sectional comparative assessment of haemophilic arthropathy","volume":"26","author":"Putz","year":"2020","journal-title":"Haemophilia"},{"issue":"09","key":"10.1016\/j.blre.2026.101418_bb0195","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1055\/a-2071-0477","article-title":"Activation of the acute-phase response in hemophilia","volume":"123","author":"Knowles","year":"2023","journal-title":"Thromb Haemost"},{"issue":"2","key":"10.1016\/j.blre.2026.101418_bb0200","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/hae.13384","article-title":"The role of sclerostin\/dickkopf-1 and receptor activator of nuclear factor kB ligand\/osteoprotegerin signalling pathways in the development of osteoporosis in patients with haemophilia A and B: a cross-sectional study","volume":"24","author":"Anagnostis","year":"2018","journal-title":"Haemophilia"},{"issue":"7","key":"10.1016\/j.blre.2026.101418_bb0205","doi-asserted-by":"crossref","first-page":"939","DOI":"10.3390\/jcm8070939","article-title":"TNF-\u03b1\/TNF-R system may represent a crucial mediator of proliferative synovitis in hemophilia A","volume":"8","author":"Manetti","year":"2019","journal-title":"J Clin Med"},{"issue":"2","key":"10.1016\/j.blre.2026.101418_bb0210","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/hae.12271","article-title":"The clinical utility of bone turnover markers in the evaluation of bone disease in patients with haemophilia A and B","volume":"20","author":"Anagnostis","year":"2014","journal-title":"Haemophilia"},{"issue":"6","key":"10.1016\/j.blre.2026.101418_bb0215","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1111\/hae.14861","article-title":"Subclinical synovial proliferation in patients with severe haemophilia A: the value of ultrasound screening and biochemical markers","volume":"29","author":"Van Bergen","year":"2023","journal-title":"Haemophilia"},{"issue":"1","key":"10.1016\/j.blre.2026.101418_bb0220","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/art.24184","article-title":"The combination of the biomarkers urinary C-terminal telopeptide of type II collagen, serum cartilage oligomeric matrix protein, and serum chondroitin sulfate 846 reflects cartilage damage in hemophilic arthropathy","volume":"60","author":"Jansen","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.blre.2026.101418_bb0225","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/hae.12637","article-title":"Point-of-care musculoskeletal ultrasound is critical for the diagnosis of hemarthroses, inflammation and soft tissue abnormalities in adult patients with painful haemophilic arthropathy","volume":"21","author":"Kidder","year":"2015","journal-title":"Haemophilia"},{"issue":"4","key":"10.1016\/j.blre.2026.101418_bb0230","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/1440-1681.13054","article-title":"Increased serum levels of progranulin (PGRN) in patients with haemophilic arthropathy","volume":"46","author":"Kotela","year":"2019","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"46","key":"10.1016\/j.blre.2026.101418_bb0235","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000005384","article-title":"Soluble vascular cell adhesion molecular-1 is a potential biological indicator of hemophilic arthropathy","volume":"95","author":"Tseng","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"10.1016\/j.blre.2026.101418_bb0240","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ejr.2015.09.005","article-title":"Serum cartilage oligomeric matrix protein reflects radiological damage and functional status in hemophilic arthropathy patients","volume":"38","author":"Hassab","year":"2016","journal-title":"Egypt Rheumatol"},{"issue":"5","key":"10.1016\/j.blre.2026.101418_bb0245","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1111\/hae.14593","article-title":"Endothelial specific isoform of type XVIII collagen (COL-18N): a marker of vascular integrity in haemophilic arthropathy","volume":"28","author":"Tantawy","year":"2022","journal-title":"Haemophilia"},{"issue":"7","key":"10.1016\/j.blre.2026.101418_bb0250","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/MBC.0000000000000131","article-title":"The investigation of relationship between joint findings and serum angiogenic and inflammatory factor levels in severe hemophilia A patients","volume":"25","author":"Karapinar","year":"2014","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"9","key":"10.1016\/j.blre.2026.101418_bb0255","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.70046","article-title":"Proteomic exploration of potential blood biomarkers in haemophilic arthropathy","volume":"7","author":"Kalebota","year":"2024","journal-title":"Health Sci Rep"},{"issue":"6","key":"10.1016\/j.blre.2026.101418_bb0260","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1111\/hae.15115","article-title":"Assessment of haemophilic joints in a low-resourced area using clinical tools: the effect of different types of prophylaxis","volume":"30","author":"Youssry","year":"2024","journal-title":"Haemophilia"},{"issue":"4","key":"10.1016\/j.blre.2026.101418_bb0265","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1111\/hae.14041","article-title":"Tissue-inhibitors of metalloproteinase-1 and vascular-endothelial growth-factor in severe haemophilia A children on low dose prophylactic recombinant factor VIII: relation to subclinical arthropathy","volume":"26","author":"Andrawes","year":"2020","journal-title":"Haemophilia"},{"issue":"7","key":"10.1016\/j.blre.2026.101418_bb0270","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1016\/j.jtha.2023.03.030","article-title":"Poor correlation between biomarkers and MRI-detected joint damage in a cross-sectional study of persons with nonsevere hemophilia A (DYNAMO study)","volume":"21","author":"Kloosterman","year":"2023","journal-title":"J Thromb Haemost"},{"issue":"5","key":"10.1016\/j.blre.2026.101418_bb0275","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1111\/hae.12936","article-title":"Potential biomarkers of haemophilic arthropathy: correlations with compatible additive magnetic resonance imaging scores","volume":"22","author":"Oldenburg","year":"2016","journal-title":"Haemophilia"},{"issue":"2","key":"10.1016\/j.blre.2026.101418_bb0280","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/bjh.13481","article-title":"High serum sclerostin levels in children with haemophilia A","volume":"172","author":"Giordano","year":"2016","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.blre.2026.101418_bb0285","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s12098-019-02855-1","article-title":"Serum sclerostin level and bone mineral density in pediatric hemophilic arthropathy","volume":"86","author":"El-Mikkawy","year":"2019","journal-title":"Indian J Pediatr"},{"issue":"6","key":"10.1016\/j.blre.2026.101418_bb0290","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1111\/hae.14881","article-title":"Neuroinflammatory markers in patients with haemophilia and healthy controls: where are the differences?","volume":"29","author":"Wehmeier","year":"2023","journal-title":"Haemophilia"},{"issue":"1","key":"10.1016\/j.blre.2026.101418_bb0295","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2516.2010.02385.x","article-title":"Comparative study of dual energy X-ray absorptiometry and quantitative ultrasonography with the use of biochemical markers of bone turnover in boys with haemophilia","volume":"17","author":"Christoforidis","year":"2011","journal-title":"Haemophilia"},{"issue":"1","key":"10.1016\/j.blre.2026.101418_bb0300","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s43166-023-00172-2","article-title":"Assessment of vascular endothelial growth factor a serum level in pediatric hemophilic arthropathy","volume":"50","author":"Saboony","year":"2023","journal-title":"Egypt Rheumatol Rehabil"},{"issue":"1","key":"10.1016\/j.blre.2026.101418_bb0305","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1365-2516.2011.02587.x","article-title":"Evaluation of bone mineral density in Turkish children with severe haemophilia A: ankara hospital experience","volume":"18","author":"Alioglu","year":"2012","journal-title":"Haemophilia"},{"issue":"16","key":"10.1016\/j.blre.2026.101418_bb0310","doi-asserted-by":"crossref","first-page":"4711","DOI":"10.3390\/jcm11164711","article-title":"The profile of markers of bone turnover, inflammation and extracellular neutrophil traps on bone mass in haemophilia and the development of haemophilic arthropathy","volume":"11","author":"Czajkowska","year":"2022","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.blre.2026.101418_bb0315","doi-asserted-by":"crossref","DOI":"10.1111\/hae.14200","article-title":"Biomarkers and immunological parameters in haemophilia and rheumatoid arthritis patients: a comparative multiplexing laboratory study","volume":"27","author":"Toenges","year":"2021","journal-title":"Haemophili"},{"key":"10.1016\/j.blre.2026.101418_bb0320","doi-asserted-by":"crossref","DOI":"10.1177\/1076029619892683","article-title":"Diagnostic values of inflammatory and angiogenic factors for acute joint bleeding in patients with severe hemophilia A","volume":"26","author":"Xu","year":"2020","journal-title":"Clin Appl Thromb"},{"issue":"1","key":"10.1016\/j.blre.2026.101418_bb0325","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00277-009-0759-x","article-title":"Increased bone resorption is implicated in the pathogenesis of bone loss in hemophiliacs: correlations with hemophilic arthropathy and HIV infection","volume":"89","author":"Katsarou","year":"2010","journal-title":"Ann Hematol"},{"issue":"1","key":"10.1016\/j.blre.2026.101418_bb0330","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/hae.13986","article-title":"Biomarkers of bone disease in persons with haemophilia","volume":"27","author":"Goldscheitter","year":"2021","journal-title":"Haemophilia"},{"issue":"1","key":"10.1016\/j.blre.2026.101418_bb0335","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3897\/folmed.65.e75414","article-title":"A single-center study of bone mineral density in adult patients with severe hemophilia A in correlation with markers of bone metabolism","volume":"65","author":"Ivanova","year":"2023","journal-title":"Folia Med (Plovdiv)"},{"issue":"7","key":"10.1016\/j.blre.2026.101418_bb0340","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3390\/jcm6070063","article-title":"Pathophysiology of Hemophilic Arthropathy","volume":"6","author":"Melchiorre","year":"2017","journal-title":"J Clin Med"},{"issue":"8","key":"10.1016\/j.blre.2026.101418_bb0345","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.3899\/jrheum.120370","article-title":"RANK-RANKL-OPG in hemophilic arthropathy: from clinical and imaging diagnosis to histopathology","volume":"39","author":"Melchiorre","year":"2012","journal-title":"J Rheumatol"},{"issue":"3","key":"10.1016\/j.blre.2026.101418_bb0350","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/ejh.12227","article-title":"Angiogenesis is increased in advanced haemophilic joint disease and characterised by normal pericyte coverage","volume":"92","author":"Zetterberg","year":"2014","journal-title":"Eur J Haematol"},{"issue":"10","key":"10.1016\/j.blre.2026.101418_bb0355","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.joca.2023.06.005","article-title":"Fundamentals of osteoarthritis: inflammatory mediators in osteoarthritis","volume":"31","author":"De Roover","year":"2023","journal-title":"Osteoarthr Cartil"},{"issue":"11","key":"10.1016\/j.blre.2026.101418_bb0360","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1016\/j.joca.2015.02.009","article-title":"Inflammatory biomarkers in osteoarthritis","volume":"23","author":"Daghestani","year":"2015","journal-title":"Osteoarthr Cartil"},{"issue":"1","key":"10.1016\/j.blre.2026.101418_bb0365","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.aller.2013.11.003","article-title":"Inflammatory markers in patients with rheumatoid arthritis","volume":"43","author":"Shrivastava","year":"2015","journal-title":"Allergol Immunopathol (Madr)"},{"issue":"6","key":"10.1016\/j.blre.2026.101418_bb0370","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1111\/hae.15097","article-title":"Pathogenesis of osteoarthritis, rheumatoid arthritis, and hemophilic arthropathy: the role of angiogenesis","volume":"30","author":"Caliogna","year":"2024","journal-title":"Haemophilia"},{"issue":"4","key":"10.1016\/j.blre.2026.101418_bb0375","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s00774-024-01520-8","article-title":"Inflammatory diseases causing joint and bone destruction: rheumatoid arthritis and hemophilic arthropathy","volume":"42","author":"Terashima","year":"2024","journal-title":"J Bone Miner Metab"},{"issue":"9","key":"10.1016\/j.blre.2026.101418_bb0380","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1111\/j.1538-7836.2010.03962.x","article-title":"Blood-induced joint disease: the pathophysiology of hemophilic arthropathy","volume":"8","author":"Valentino","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.blre.2026.101418_bb0385","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/hae.70171","article-title":"Identification of iron overload\u2013associated biomarkers in the synovium of haemophilic arthropathy","volume":"32","author":"Hu","year":"2026","journal-title":"Haemophilia"},{"issue":"1","key":"10.1016\/j.blre.2026.101418_bb0390","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1038\/s41598-025-89253-0","article-title":"Association between serum high-sensitivity C-reactive protein levels and osteoarthritis in adults from NHANES 2015 to 2018","volume":"15","author":"Gao","year":"2025","journal-title":"Sci Rep"},{"issue":"3","key":"10.1016\/j.blre.2026.101418_bb0395","doi-asserted-by":"crossref","first-page":"R208","DOI":"10.1186\/ar1166","article-title":"Relationship between radiographic grading of osteoarthritis and the biochemical markers for arthritis in knee osteoarthritis","volume":"6","author":"Takahashi","year":"2004","journal-title":"Arthritis Res Ther"},{"issue":"4","key":"10.1016\/j.blre.2026.101418_bb0400","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3892\/etm.2022.11206","article-title":"Monomeric C-reactive protein level is associated with osteoarthritis","volume":"23","author":"Liang","year":"2022","journal-title":"Exp Ther Med"},{"issue":"11","key":"10.1016\/j.blre.2026.101418_bb0405","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1136\/ard.2009.125260","article-title":"Serum C reactive protein levels and genetic variation in the CRP gene are not associated with the prevalence, incidence or progression of osteoarthritis independent of body mass index","volume":"69","author":"Kerkhof","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.blre.2026.101418_bb0410","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.30225","article-title":"Role of high-sensitivity c-reactive protein (Hs-CRP) in non-communicable diseases: a review","author":"Banait","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.blre.2026.101418_bb0415","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2147\/CIA.S242288","article-title":"Soluble biomarkers of osteoporosis and osteoarthritis, from pathway mapping to clinical trials: an update","volume":"15","author":"Nagy","year":"2020","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.blre.2026.101418_bb0420","series-title":"Vascular Endothelial Growth Factor (VEGF) and Its Role in Non-Endothelial Cells: Autocrine Signalling by VEGF","author":"Angela","year":"2026"},{"issue":"1","key":"10.1016\/j.blre.2026.101418_bb0425","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1186\/1471-2474-15-437","article-title":"Elevated VEGF levels contribute to the pathogenesis of osteoarthritis","volume":"15","author":"Yuan","year":"2014","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/j.blre.2026.101418_bb0430","series-title":"Clinical and Experimental Rheumatology","author":"Joo","year":"2001"},{"key":"10.1016\/j.blre.2026.101418_bb0435","doi-asserted-by":"crossref","DOI":"10.1016\/j.sna.2021.112975","article-title":"Recent advances in biosensors for detection of osteoarthritis and rheumatoid arthritis biomarkers","volume":"331","author":"Mobed","year":"2021","journal-title":"Sensors Actuators A Phys"},{"issue":"1","key":"10.1016\/j.blre.2026.101418_bb0440","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.joca.2014.09.008","article-title":"Biochemical markers of joint tissue damage increase shortly after a joint bleed; an explorative human and canine in vivo study","volume":"23","author":"Van Vulpen","year":"2015","journal-title":"Osteoarthr Cartil"},{"issue":"4","key":"10.1016\/j.blre.2026.101418_bb0445","doi-asserted-by":"crossref","DOI":"10.1111\/hae.13554","article-title":"The combination of urinary CTX - II and serum CS -846: Promising biochemical markers to predict radiographic progression of haemophilic arthropathy\u2014An exploratory study","volume":"24","author":"Pulles","year":"2018","journal-title":"Haemophilia"},{"issue":"8","key":"10.1016\/j.blre.2026.101418_bb0450","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1080\/14789450.2021.1952868","article-title":"Mass spectrometry-based biomarkers for knee osteoarthritis: a systematic review","volume":"18","author":"Haartmans","year":"2021","journal-title":"Expert Rev Proteomics"},{"issue":"2","key":"10.1016\/j.blre.2026.101418_bb0455","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3390\/bios11020031","article-title":"Biosensors for detection of biochemical markers relevant to osteoarthritis","volume":"11","author":"Longo","year":"2021","journal-title":"Biosensors"},{"issue":"1","key":"10.1016\/j.blre.2026.101418_bb0460","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jtha.2023.08.035","article-title":"Evaluation of collagen turnover biomarkers as an objective measure for efficacy of treatment with rurioctocog alfa pegol in patients with hemophilia A: a secondary analysis of a randomized controlled trial","volume":"22","author":"Manon-Jensen","year":"2024","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.blre.2026.101418_bb0465","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/hae.70023","article-title":"Comorbidity and mortality in men and women with haemophilia in three nordic countries\u2013comparisons to matched controls","volume":"31","author":"Steen Carlsson","year":"2025","journal-title":"Haemophilia"},{"issue":"1","key":"10.1016\/j.blre.2026.101418_bb0470","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1097\/BOR.0000000000000845","article-title":"Blood and urine biomarkers in osteoarthritis \u2013 an update on cartilage associated type II collagen and aggrecan markers","volume":"34","author":"Bay-Jensen","year":"2022","journal-title":"Curr Opin Rheumatol"},{"issue":"5","key":"10.1016\/j.blre.2026.101418_bb0475","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1111\/jth.15268","article-title":"Systemic vascular basement membrane markers linked to synovial vascular remodeling are biomarkers of hemarthrosis in patients with hemophilia","volume":"19","author":"Gopal","year":"2021","journal-title":"J Thromb Haemost"},{"issue":"8","key":"10.1016\/j.blre.2026.101418_bb0480","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1053\/joca.2002.0800","article-title":"C-reactive protein as a biomarker of emergent osteoarthritis","volume":"10","author":"Sowers","year":"2002","journal-title":"Osteoarthr Cartil"},{"issue":"8","key":"10.1016\/j.blre.2026.101418_bb0485","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1097\/MBC.0000000000000957","article-title":"High prevalence of overweight\/obesity in adult persons with hemophilia in Utah and a review of the literature","volume":"31","author":"Lim","year":"2020","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"1","key":"10.1016\/j.blre.2026.101418_bb0490","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.diabres.2004.11.007","article-title":"Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-\u03b1 and IL-6","volume":"69","author":"Park","year":"2005","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"10.1016\/j.blre.2026.101418_bb0495","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.blre.2026.101418_bb0500","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00198-025-07422-3","volume":"36","author":"Bhattoa","year":"2025","journal-title":"Osteoporos Int"},{"issue":"2","key":"10.1016\/j.blre.2026.101418_bb0505","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/hae.14508","article-title":"DNA extracellular traps as potential biomarker of chronic haemophilic synovitis and therapeutic perspective in patients treated with PRP: a pilot study","volume":"28","author":"Oneto","year":"2022","journal-title":"Haemophilia"},{"issue":"11","key":"10.1016\/j.blre.2026.101418_bb0510","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.3390\/ijms22115711","article-title":"Small noncoding RNAs in knee osteoarthritis: the role of MicroRNAs and tRNA-derived fragments","volume":"22","author":"Zacharjasz","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.blre.2026.101418_bb0515","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pbiomolbio.2022.09.007","article-title":"lncRNA-mediated synovitis in rheumatoid arthritis: a perspective for biomarker development","volume":"175","author":"Ravaei","year":"2022","journal-title":"Prog Biophys Mol Biol"},{"issue":"17","key":"10.1016\/j.blre.2026.101418_bb0520","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241713144","article-title":"Exploring the feasibility of circulating miRNAs as diagnostic and prognostic biomarkers in osteoarthritis: challenges and opportunities","volume":"24","author":"Felekkis","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.blre.2026.101418_bb0525","doi-asserted-by":"crossref","DOI":"10.1016\/j.semarthrit.2023.152163","article-title":"Utilizing metabolomics to identify potential biomarkers and perturbed metabolic pathways in osteoarthritis: a systematic review","volume":"59","author":"Van Pevenage","year":"2023","journal-title":"Semin Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.blre.2026.101418_bb0530","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2174\/1566524023666230423144114","article-title":"Structural and pharmacological network focused on MiRNAs involved in rheumatoid arthritis: a systematic review","volume":"24","author":"Barrera-V\u00e1zquez","year":"2024","journal-title":"Curr Mol Med"},{"issue":"4","key":"10.1016\/j.blre.2026.101418_bb0535","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3390\/biom10040589","article-title":"The clinical potential of circulating miRNAs as biomarkers: present and future applications for diagnosis and prognosis of age-associated bone diseases","volume":"10","author":"Bottani","year":"2020","journal-title":"Biomolecules"},{"issue":"7\u20138","key":"10.1016\/j.blre.2026.101418_bb0540","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jpain.2019.12.002","article-title":"Epigenetic and miRNA expression changes in people with pain: a systematic review","volume":"21","author":"Polli","year":"2020","journal-title":"J Pain"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X26000573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X26000573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T21:05:35Z","timestamp":1787951135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X26000573"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":109,"alternative-id":["S0268960X26000573"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2026.101418","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers of joint and bone diseases, and their associations to haemophilic arthropathy in people with haemophilia: A first systematic review","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2026.101418","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101418"}}